Pappot H - Search Results

1

Active use of electronic patient-reported outcome in kidney cancer and effect on self-reported physical function: PRORECECA study protocol.

Rasmussen IML, Moeller AKH, Soerensen AV, Persson G, Taarnhoej GA, Palshof JA, Pappot H. Rasmussen IML, et al. Among authors: pappot h. Acta Oncol. 2022 Dec;61(12):1473-1476. doi: 10.1080/0284186X.2022.2145912. Epub 2022 Dec 9. Acta Oncol. 2022. PMID: 36494192 No abstract available.

2

[Women and lung cancer--epidemiology, smoking and biology].

Fischer BM, Elberling C, Skuladottir H, Nøttrup TJ, Christensen C, Pappot H. Fischer BM, et al. Among authors: pappot h. Ugeskr Laeger. 2003 Nov 17;165(47):4550-2. Ugeskr Laeger. 2003. PMID: 14677237 Danish. No abstract available.

3

Association between plasma concentrations of plasminogen activator inhibitor-1 and survival in patients with colorectal cancer.

Nielsen HJ, Pappot H, Christensen IJ, Brünner N, Thorlacius-Ussing O, Moesgaard F, Danø K, Grøndahl-Hansen J. Nielsen HJ, et al. Among authors: pappot h. BMJ. 1998 Mar 14;316(7134):829-30. doi: 10.1136/bmj.316.7134.829. BMJ. 1998. PMID: 9549453 Free PMC article. No abstract available.

4

ELISA for complexes between urokinase-type plasminogen activator and its receptor in lung cancer tissue extracts.

de Witte H, Pappot H, Brünner N, Grøndahl-Hansen J, Hoyer-Hansen G, Behrendt N, Guldhammer-Skov B, Sweep F, Benraad T, Danø K. de Witte H, et al. Among authors: pappot h. Int J Cancer. 1997 Jul 29;72(3):416-23. doi: 10.1002/(sici)1097-0215(19970729)72:3<416::aid-ijc8>3.0.co;2-s. Int J Cancer. 1997. PMID: 9247284 Free article.

5

[Lung cancer--a technological challenge I. Diagnostics and staging].

Nøttrup TJ, Fischer BM, Almasi CE, Skuladottir H, Pappot H. Nøttrup TJ, et al. Among authors: pappot h. Ugeskr Laeger. 2004 Nov 15;166(47):4241-3. Ugeskr Laeger. 2004. PMID: 15587352 Danish. No abstract available.

6

Presence of urokinase plasminogen activator, its inhibitor and receptor in small cell lung cancer and non-small cell lung cancer.

Pappot H, Pfeiffer P, Grondahlhansen J, Skov B. Pappot H, et al. Int J Oncol. 1997 Jan;10(1):177-82. doi: 10.3892/ijo.10.1.177. Int J Oncol. 1997. PMID: 21533361

7

[Lung cancer--a technological challenge II. New approaches to treatment].

Pappot H, Fischer BM, Almasi CE, Skuladottir H, Nøttrup TJ. Pappot H, et al. Ugeskr Laeger. 2004 Nov 15;166(47):4243-5. Ugeskr Laeger. 2004. PMID: 15587353 Danish. No abstract available.

8

[Combination chemotherapy for treatment of metastasing non-small-cell lung carcinoma. Monotherapy of combinations of two or three agents--a survey of a Cochrane review].

Mellemgaard A, Pappot H. Mellemgaard A, et al. Among authors: pappot h. Ugeskr Laeger. 2009 Jun 15;171(25):2084-7. Ugeskr Laeger. 2009. PMID: 19671386 Review. Danish. No abstract available.

9

Erratum: Vinflunine treatment in patients with metastatic urothelial cancer: A Nordic retrospective multicenter analysis.

Holmsten K, Dohn L, Jensen NV, Shah CH, Jäderling F, Pappot H, Ullén A. Holmsten K, et al. Among authors: pappot h. Oncol Lett. 2017 Jun;13(6):5035. doi: 10.3892/ol.2017.6082. Epub 2017 Apr 24. Oncol Lett. 2017. PMID: 28588741 Free PMC article.

10

Comparing the patients' subjective experiences of acute side effects during radiotherapy for head and neck cancer with four different patient-reported outcomes questionnaires.

Holländer-Mieritz C, Johansen J, Johansen C, Vogelius IR, Kristensen CA, Pappot H. Holländer-Mieritz C, et al. Among authors: pappot h. Acta Oncol. 2019 May;58(5):603-609. doi: 10.1080/0284186X.2018.1563713. Epub 2019 Jan 30. Acta Oncol. 2019. PMID: 30698098

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

166 results

Search Page

Filters